Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection

ClinicalTrials.gov ID: NCT01780831

Public ClinicalTrials.gov record NCT01780831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Trial to Evaluate the Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Neonates at Risk of Acquiring HIV-1 Infection

Study identification

NCT ID
NCT01780831
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
52 participants

Conditions and interventions

Conditions

Interventions

  • Raltegravir Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 27, 2014
Primary completion
Dec 13, 2017
Completion
Apr 19, 2018
Last update posted
Nov 4, 2021

2014 – 2018

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Usc La Nichd Crs Los Angeles California 90089
Children's National Med. Ctr. Washington DC NICHD CRS Washington D.C. District of Columbia 20010
Univ. of Florida Jacksonville NICHD CRS Jacksonville Florida 32209
Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago Illinois 60612
Lurie Children's Hospital of Chicago (LCH) CRS Chicago Illinois 60614-3393
Boston Medical Center Ped. HIV Program NICHD CRS Boston Massachusetts 02118
Bronx-Lebanon Hospital Center NICHD CRS The Bronx New York 10457
St. Jude Children's Research Hospital CRS Memphis Tennessee 38105-3678

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01780831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01780831 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →